Article Details
Retrieved on: 2024-01-25 17:28:33
Tags for this article:
Click the tags to see associated articles and topics
Summary
Assenagon Asset Management S.A. significantly increased its holdings in Pfizer, consistent with general institutional investor activity. The article discusses Pfizer's stock performance, analyst ratings, dividend information, and company profile, relating to equity securities and the stock market, especially in the context of Fintech advancements impacting investment strategies.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here